Research summary, original research, 2016

Getting to zero: impact of electroanatomical mapping on fluoroscopy use in pediatric catheter ablation

Clark BC, Sumihara K, McCarter R, Berul CI, Moak JP. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 2016

Read the original paper

In plain language

At one children's hospital, adding 3D electroanatomic mapping to catheter ablation cut fluoroscopy time, with about a third of cases done with no fluoroscopy. Only patient dose was measured, though less fluoroscopy likely also lowers exposure for the electrophysiology (EP) team.

At a glance

Type of study
Original research, Retrospective cohort study
Who was studied
Patients
Summary based on
the abstract

What it found

  • Mean fluoroscopy time fell after introduction of CARTO 3 electroanatomic mapping in normal heart, congenital heart disease and trans-septal groups.

    Key figures: p < 0.01

  • Zero fluoroscopy was achieved in nearly a third of cases, and fluoroscopy time of 1 minute or less in almost half.

    Key figures: 50/159 (31 %) zero fluoroscopy; 71/159 (45 %) ≤1 min

  • Fluoroscopy time decreased for accessory pathway and atrioventricular nodal reentrant tachycardia (AVNRT) ablations.

    Key figures: p < 0.0001

  • After adjustment for age, weight and diagnosis, fluoroscopy time fell in all groups, and radiation dose and dose-area product (DAP) fell in the normal heart group.

Limits to keep in mind

Single-centre retrospective before-after comparison at a children's hospital; only patient radiation metrics were reported, so staff dose reduction is inferred rather than measured. Total sample size across periods not stated in the abstract.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.